Skip to main content

Table 1 Gas exchange and haemodynamics

From: Comparative effects of flow vs. volume-controlled one-lung ventilation on gas exchange and respiratory system mechanics in pigs

Parameter

Therapy

ANOVA (P=)

Group

Mode

20′

40′

60′

Seq

Group

Mode

Time

Mixed

MAP (mmHg)

    

0.335

0.228

0.329

0.070

0.188

 Norm

VCV

80 ± 13

76 ± 13

72 ± 14

     

FCV

74 ± 15

73 ± 17

78 ± 28

     

 Hypo

VCV

65 ± 20

65 ± 20

63 ± 22

     

FCV

69 ± 17

67 ± 17

64 ± 17

     

MPAP (mmHg)

    

0.292

0.854

0.392

0.946

0.962

 Norm

VCV

28 ± 8

26 ± 8

27 ± 7

     

FCV

27 ± 8

27 ± 6

27 ± 4

     

 Hypo

VCV

27 ± 7

28 ± 6

28 ± 5

     

FCV

26 ± 7

25 ± 6

25 ± 7

     

CVP (mmHg)

    

0.380

0.066

0.368

0.738

0.875

 Norm

VCV

4 ± 4

4 ± 4

5 ± 5

     

FCV

4 ± 3

3 ± 2

4 ± 2

     

 Hypo

VCV

2 ± 1

2 ± 2

2 ± 2

     

FCV

1 ± 2

2 ± 3

1 ± 2

     

CO (l/min)

    

0.744

0.102

0.456

0.540

0.369

 Norm

VCV

7.26 ± 1.95

7.19 ± 1.53

7.51 ± 1.21

     

FCV

7.22 ± 1.46

7.1 ± 1.42

6.82 ± 1.67

     

 Hypo

VCV

8.59 ± 3.74

8.68 ± 2.75

8.88 ± 2.57

     

FCV

8.95 ± 2.64

8.91 ± 2.37

8.76 ± 2.24

     

EVLW (mL)

    

0.868

0.106

0.764

0.146

0.646

 Norm

VCV

446 ± 69

455 ± 62

448 ± 61

     

FCV

438 ± 41

439 ± 41

438 ± 44

     

 Hypo

VCV

559 ± 179

536 ± 158

499 ± 127

     

FCV

562 ± 203

560 ± 169

530 ± 180

     

ITBV (mL)

    

0.008

0.210

0.929

0.879

0.949

 Norm

VCV

582 ± 167

566 ± 141

605 ± 173

     

FCV

587 ± 222

574 ± 240

560 ± 205

     

 Hypo

VCV

502 ± 90

484 ± 88

487 ± 96

     

FCV

501 ± 128

501 ± 118

540 ± 181

     

GEDV (mL)

    

0.008

0.220

0.999

0.974

0.882

 Norm

VCV

466 ± 134

450 ± 114

484 ± 138

     

FCV

470 ± 177

459 ± 192

449 ± 164

     

 Hypo

VCV

407 ± 70

387 ± 70

390 ± 77

     

FCV

401 ± 103

401 ± 94

432 ± 145

     

SVR (dyn*s/cm5)

    

0.251

0.156

0.759

0.090

0.870

 Norm

VCV

955 ± 294

878 ± 284

805 ± 236

     

FCV

1100 ± 436

858 ± 254

940 ± 242

     

 Hypo

VCV

736 ± 433

726 ± 410

682 ± 392

     

FCV

717 ± 306

720 ± 319

700 ± 325

     

Noradrenalin (mg/h)

    

0.607

0.031

0.912

0.534

0.790

 Norm

VCV

0.28 ± 0.50

0.78 ± 1.39

0.28 ± 0.50

     

FCV

0.23 ± 0.39

0.27 ± 0.48

0.28 ± 0.48

     

 Hypo

VCV

1.94 ± 2.19

2.04 ± 2.22

2.25 ± 2.59

 

0.054

   

FCV

2.12 ± 2.15

2.18 ± 2.28

2.19 ± 2.55

 

0.022

   

Hb (mmol/L)

    

0.483

0.302

0.212

0.678

0.695

 Norm

VCV

5.81 ± 0.91

5.64 ± 0.95

5.75 ± 1

     

FCV

5.92 ± 1.05

5.78 ± 1.07

5.69 ± 0.85

     

 Hypo

VCV

5.19 ± 0.97

5.11 ± 0.98

5.14 ± 0.91

     

FCV

5.46 ± 0.95

5.45 ± 0.94

5.44 ± 0.87

     

Shunt (%)

    

0.944

0.103

0.097

0.050

0.114

 Norm

VCV

32.8 ± 11.1

29.8 ± 8.9

29.9 ± 10.2

     

FCV

32.5 ± 8.2

32.2 ± 7.7

30.8 ± 8.2

     

 Hypo

VCV

41.7 ± 11.3

40.2 ± 11.6

38.3 ± 10.4

     

FCV

37 ± 9.8

37.7 ± 10.5

39.6 ± 12.1

     
  1. Values in mean ± standard deviation; Statistical P values according to linear mixed-effects repeated measures ANOVA with with-in subject factors: mode of ventilation (volume or flow-controlled ventilation) and time of therapy in minutes; and between subject factors group of therapy (normovolaemia or hypovolaemia) and randomisation sequence (volume or flow-controlled ventilation first). Significance was accepted for P < 0.05. Statistical analysis was performed in R statistical programming language and the package lme4
  2. FCV flow-controlled ventilation, VCV volume-controlled ventilation, MAP mean arterial pressure, MPAP mean pulmonary arterial pressure, CVP central venous pressure, CO cardiac output, EVLW extravascular lung water, ITBV intrathoracic blood volume, GEDV global end-diastolic volume, SVR systemic vascular resistance, Hb haemoglobin, Shunt intrapulmonary shunt